Inventor · disambiguated record
Yanli Wu
Also filed as: WU YANLI
6 granted patents·7 pending applications·366 citations·filing 2008–2023
86Inventor score
Top patents by PatentIndex Score
13 records- 0197US7960515B2Binding molecules to the human OX40 receptorBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 14, 2011·205 cites·12 claims
- 0296US8236930B2Binding molecules to the human OX40 receptorMIN JING·Filed 2011·Granted Aug 7, 2012·85 cites·5 claims
- 0395US9028824B2Binding molecules to the human OX40 receptorMIN JING·Filed 2012·Granted May 12, 2015·75 cites·22 claims
- 0478US10196452B2Binding molecules to the human OX40 receptorPFIZER·Filed 2017·Granted Feb 5, 2019·1 cites·16 claims
- 0576US2022002428A1Binding molecules to the human ox40 receptorPFIZER·Filed 2021·Application pending·0 cites
- 0676US2024124612A1Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic propertiesMEDIMMUNE LLC·Filed 2023·Application pending·0 cites
- 0768US11767369B2Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic propertiesMEDIMMUNE LLC·Filed 2019·Granted Sep 26, 2023·0 cites·26 claims
- 0867US2019135932A1Binding molecules to the human ox40 receptorPFIZER·Filed 2019·Application pending·0 cites
- 0959US9840562B2Binding molecules to the human OX40 receptorPFIZER·Filed 2015·Granted Dec 12, 2017·0 cites·24 claims
- 1057US2020277381A1Alpha-v beta-8 antibodiesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1153US2023112035A1ANTI-avB8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY DISEASEMEDIMMUNE LTD·Filed 2021·Application pending·0 cites
- 1251US2017267780A1Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic propertiesMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 1345US2017129955A1Alpha-v beta-8 antibodiesUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yanli Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →